Malathi Kandarpa
Assistant Research Scientist
Internal Medicine
[email protected]

Available to mentor
Malathi Kandarpa
Assistant Research Scientist
  • Qualifications
  • Recent Publications
    • Qualifications
    • Postdoctoral Fellow
      The University of Texas Health Science Center at Houston, Houston, 2002
    • Postdoctoral Scientist
      Wyeth Pharmaceticals, Pearl River
    • PhD
      Purdue University, West Lafayette, 2000
    • MS
      All India Institute of Medical Sciences, New Delhi, 1994
    • BSc
      All India Institute of Medical Sciences, New Delhi, 1992
    Recent Publications See All Publications
    • Journal Article
      Broad next generation integrated sequencing of myelofibrosis identifies disease-specific and age-related genomic alterations.
      Kandarpa M, Robinson D, Wu Y-M, Qin T, Pettit K, Li Q, Luker G, Sartor M, Chinnaiyan A, Talpaz M. Clin Cancer Res, 2024 Feb 22; DOI:10.1158/1078-0432.CCR-23-0372
      PMID: 38386293
    • Journal Article
      ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer.
      Bhambhani C, Kang Q, Hovelson DH, Sandford E, Olesnavich M, Dermody SM, Wolfgang J, Tuck KL, Brummel C, Bhangale AD, He K, Gutierrez MG, Lindstrom RH, Liu C-J, Tuck M, Kandarpa M, Mierzwa M, Casper K, Prince ME, Krauss JC, Talpaz M, Henry NL, Giraldez MD, Ramnath N, Tomlins SA, Swiecicki PL, Brenner JC, Tewari M. JCI Insight, 2024 Feb 8; 9 (6): DOI:10.1172/jci.insight.177759
      PMID: 38516891
    • Journal Article
      Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling.
      Reynolds SB, Pettit K, Kandarpa M, Talpaz M, Li Q. Cancers (Basel), 2023 Sep 21; 15 (18): DOI:10.3390/cancers15184654
      PMID: 37760623
    • Journal Article
      Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.
      Phillips TJ, Bond D, Takiar R, Kump K, Kandarpa M, Boonstra P, Mayer TL, Nachar V, Wilcox RA, Carty SA, Karimi YH, Nikolovska-Coleska Z, Kaminski MS, Herrera AF, Maddocks K, Popplewell L, Danilov AV. Blood Adv, 2023 Aug 22; 7 (16): 4518 - 4527. DOI:10.1182/bloodadvances.2023009992
      PMID: 37013954
    • Journal Article
      Pneumocystis Jirovecii Infection in Autologous Hematopoietic Stem Cell Transplant Recipients
      Coda J, Raser K, Anand S, Ghosh M, Gregg K, Li J, Maciejewski J, Pawarode A, Riwes M, Tillman C, Polk A, Kandarpa M, Talpaz M, Choi S, Yanik G, Magenau J, Pianko M. Bone Marrow Transplantation, 2023 Apr 23; DOI:10.1038/s41409-022-01906-0
    • Proceeding / Abstract / Poster
      Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients.
      Coda J, Raser K, Anand SM, Ghosh M, Gregg K, Li J, Maciejewski JJ, Pawarode A, Riwes MM, Tillman C, Polk A, Kandarpa M, Talpaz M, Choi SW, Yanik GA, Magenau JM, Pianko MJ. Bone Marrow Transplant, 2023 Apr; 58 (4): 446 - 451. DOI:10.1038/s41409-022-01906-0
      PMID: 36550198
    • Journal Article
      Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
      Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan X-WC, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim S-H, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G. Blood Adv, 2023 Jan 10; 7 (1): 88 - 91. DOI:10.1182/bloodadvances.2022008634
      PMID: 36269847
    • Journal Article
      Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
      Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan C, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Karmali R, Kim S-H, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G. J Hematol Oncol, 2022 Jul 16; 15 (1): 96 DOI:10.1186/s13045-022-01316-1
      PMID: 35842643